# US 2025/0146022 A1 · Stabilising the human spindle by kifc1/hset

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0146022 A1
- Document ID: US20250146022A1
- Status: Published application
- Kind: A1
- Application number: 18/695,584
- Filed: 2022-07-25
- Published: 2025-05-08
- Earliest claimed: 2021-09-27
- Assignees: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.
- Applicants: Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V.
- Inventors: Melina SCHUH; Chun SO
- Web page: https://patentgrep.com/patent/US20250146022A1

## CPC

- C12N 5/0609: {Oocytes, oogonia (fertilised oocytes C12N5/0604)}
- C12N 15/89: using microinjection
- C07K 14/47: from mammals
- C12N 5/0604: {Whole embryos; Culture medium therefor}
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C12N 2510/00: Genetically modified cells
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

It has been surprisingly found that human oocytes lack the important spindle-associated protein KIFC1/HSET. The application describes a method stabilising the human spindle with KIFC1/HSET. Specifically, the method relates to introducing (i) KIFC1/HSET protein or (ii) mRNA encoding KIFC1/HSET into a human oocyte. Furthermore, the application relates to a non-naturally occurring human oocyte, wherein a (i) KIFC1/HSET protein or (ii) KIFC1/HSET mRNA has been introduced into a naturally occurring human oocyte thereby obtaining the non-naturally occurring oocyte. Additionally, the application relates to a (i) KIFC1/HSET protein or (ii) mRNA encoding the KIFC1/HSET for use in a method of lowering the probability of having a disorganized and/or a multipolar spindle during mitosis in a human zygote by introducing the (i) KIFC1/HSET protein or (ii) mRNA encoding the KIFC1/HSET into the human zygote. Moreover, the application discloses a complex comprising (i) a KIFC1/HSET protein and (ii) a human meiotic spindle or a human mitotic spindle, wherein the KIFC1/HSET protein has been introduced into a human oocyte or zygote.

## Claims

### Claim at position 1

1-21. (canceled)

### Claim 22

An in vitro method for use in assisted reproductive technology of introducing (i) KIFC1/HSET protein or (ii) mRNA encoding KIFC1/HSET into a human oocyte.

### Claim 23 (depends on 22)

The method of claim 22, wherein the KIFC1/HSET protein stabilizes the meiotic spindle of the human oocyte.

### Claim 24 (depends on 22)

The method of claim 22, wherein the KIFC1/HSET protein is recombinantly produced KIFC1/HSET protein.

### Claim 25 (depends on 22)

The method of claim 22, wherein the human oocyte is naturally occurring and/or wherein the human oocyte expresses the KIFC1/HSET protein at least 2-fold less than a mouse oocyte, at least 4-fold less than a mouse oocyte; and/or wherein the human oocyte is naturally occurring and/or wherein the human oocyte expresses KIFC1/HSET protein at least 2-fold less than a Hela cell, at least 4-fold less than a HeLa cell.

### Claim 26 (depends on 22)

The method of claim 22, wherein the human oocyte with introduced KIFC1/HSET protein or mRNA encoding KIFC1/HSET has a higher probability of having a bipolar meiotic spindle compared to the human oocyte without introduced KIFC1/HSET protein or mRNA encoding KIFC1/HSET, wherein the human oocyte with introduced KIFC1/HSET protein or mRNA encoding KIFC1/HSET has greater than, or equal to, a 5% higher probability of having a bipolar meiotic spindle compared to the human oocyte without introduced KIFC1/HSET protein or mRNA encoding KIFC1/HSET.

### Claim 27 (depends on 22)

The method of claim 22, wherein (i) the KIFC1/HSET protein or (ii) the mRNA encoding KIFC1/HSET is introduced into the human oocyte at the germinal vesicle stage, meiosis I, or meiosis II.

### Claim 28

A non-naturally occurring human oocyte, wherein the non-naturally occurring human oocyte is obtained by introduction of a suitable amount of (i) KIFC1/HSET protein or (ii) KIFC1/HSET mRNA into a naturally occurring human oocyte, wherein (i) the KIFC1/HSET protein or (ii) KIFC1/HSET protein expressed from the mRNA encoding the KIFC1/HSET stabilizes the meiotic spindle of the oocyte.

### Claim 29 (depends on 28)

The human oocyte of claim 28, wherein the naturally occurring human oocyte expresses the KIFC1/HSET at least 2-fold less than a mouse oocyte, at least 4-fold less than a mouse oocyte.

### Claim 30

A method of lowering the probability of aneuploidy by introducing (i) KIFC1/HSET protein or (ii) mRNA encoding the KIFC1/HSET into a human zygote.

### Claim 31 (depends on 30)

The method of claim 30, wherein (i) the KIFC1/HSET protein or (ii) KIFC1/HSET protein expressed from the mRNA encoding KIFC1/HSET stabilizes the mitotic spindle of the human zygote, wherein the KIFC1/HSET protein is a recombinantly produced KIFC1/HSET protein.

### Claim 32 (depends on 30)

The method of claim 30, wherein the human zygote expresses KIFC1/HSET at least 2-fold less than a mouse zygote or at least 4-fold less than a mouse zygote.

### Claim 33 (depends on 30)

The method of claim 30, wherein (i) the KIFC1/HSET protein or (ii) the mRNA encoding KIFC1/HSET is introduced into the human zygote during mitotic prophase, metaphase, anaphase, telophase, or S phase.

### Claim 34 (depends on 31)

The method of claim 31, wherein the human zygote with the stabilized mitotic spindle has a higher probability of being a bipolar spindle than a being a non-stabilized mitotic spindle, wherein the non-stabilized spindle is a multipolar or a disorganized spindle and wherein the stabilization of the mitotic spindle is assessed by spindle polarity morphology using fluorescence microscopy or polarized light microscopy.

### Claim 35

A complex in assisted reproductive technology comprising (i) a KIFC1/HSET protein and (ii) a human meiotic spindle or a human mitotic spindle, obtained by introduction of a suitable amount of the KIFC1/HSET protein into a human oocyte or zygote by an in vitro method, wherein the KIFC1/HSET protein has been introduced by microinjection and/or electroporation, wherein the complex is detectable by fluorescence microscopy, wherein the KIFC1/HSET protein stabilizes the spindle, and wherein the stabilized spindle is a bipolar spindle.
